Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers
- 5 November 2004
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 37 (5), 1130-1144
- https://doi.org/10.1016/j.biocel.2004.09.006
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- NF-κB inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifenAnnals of Oncology, 2004
- Chemoresistance: Impact of Nuclear Factor (NF)-κB Inhibition by Small Interfering RNAClinical Cancer Research, 2004
- Estrogen Withdrawal-Induced NF-κB Activity and Bcl-3 Expression in Breast Cancer Cells: Roles in Growth and Hormone IndependenceMolecular and Cellular Biology, 2003
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Protein Kinase C Induces Motility of Breast Cancers by Upregulating Secretion of Urokinase-Type Plasminogen Activator through Activation of AP-1 and NF-κBBiochemical and Biophysical Research Communications, 2002
- Role of Quinones in ToxicologyChemical Research in Toxicology, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- A c-erbB-2 Promoter-specific Nuclear Matrix Protein from Human Breast Tumor Tissues Mediates NF-κB DNA Binding ActivityPublished by Elsevier ,1997
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990